Cargando…
COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography
Patients critically ill with COVID-19 are at risk for thrombotic events despite prophylactic anticoagulation. Impaired fibrinolysis has been proposed as an underlying mechanism. Our objective was to determine if fibrinolysis stimulated by tissue plasminogen activator (tPA) differed between COVID pat...
Autores principales: | Maier, Cheryl L., Sarker, Tania, Szlam, Fania, Sniecinski, Roman M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026096/ https://www.ncbi.nlm.nih.gov/pubmed/33829396 http://dx.doi.org/10.1007/s11239-021-02438-y |
Ejemplares similares
-
COVID‐19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid
por: Moiseiwitsch, Nina, et al.
Publicado: (2022) -
Accelerated Fibrinolysis and Its Propagation on Vascular Endothelial Cells by Secreted and Retained tPA
por: Urano, Tetsumei, et al.
Publicado: (2012) -
Fibrinolysis during cardiopulmonary bypass detected with thromboelastography
por: Hájek, R, et al.
Publicado: (2007) -
Urokinase-induced fibrinolysis in thromboelastography (UKIF-TEG) to assess fibrinolysis in critically ill patients
por: Zacchetti, L, et al.
Publicado: (2013) -
tPA or not tPA? Lysis therapy in the setting of COVID‐19 and ECMO
por: Cromartie, Anjelica, et al.
Publicado: (2022)